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Misfolded, luminal endoplasmic reticulum (ER) pro-
teins are retrotranslocated into the cytosol and
degraded by the ubiquitin/proteasome system. This
ERAD-L pathway requires a protein complex consist-
ing of the ubiquitin ligase Hrd1p, which spans the ER
membrane multiple times, and the membrane
proteins Hrd3p, Usa1p, and Der1p. Here, we show
that Hrd1p is the central membrane component in
ERAD-L; its overexpression bypasses the need for
the other components of the Hrd1p complex. Hrd1p
function requires its oligomerization, which in wild-
type cells is facilitated by Usa1p. Site-specific photo-
crosslinking indicates that, at early stages of retro-
translocation, Hrd1p interacts with a substrate
segment close to the degradation signal. This inter-
action follows the delivery of substrate through other
ERAD components, requires the presence of trans-
membrane segments of Hrd1p, and depends on
both the ubiquitin ligase activity of Hrd1p and the
function of the Cdc48p ATPase complex. Our results
suggest a model for how Hrd1p promotes polypep-
tide movement through the ER membrane.
INTRODUCTION
Misfolded proteins in the lumen or membrane of the endo-
plasmic reticulum (ER) are ultimately retrotranslocated into the
cytosol, polyubiquitinated, and degraded by the proteasome
(for review, see Hirsch et al., 2009; Xie and Ng, 2010). The
process is called ER-associated protein degradation (ERAD)
and is conserved in all eukaryotes. In S. cerevisiae, substrates
use three ERAD pathways (ERAD-L, -M, and -C), depending
on whether their misfolded domain is located in the ER lumen,
in the ER membrane, or on the cytoplasmic side of the ER
membrane (Carvalho et al., 2006; Taxis et al., 2003; Vashist
and Ng, 2004). ERAD-L requires a heterotetrameric membrane
protein complex, the Hrd1p complex, comprised of the ubiquitin
ligase Hrd1p, as well as Hrd3p, Usa1p, and Der1p (Bays et al.,2001a; Bordallo et al., 1998; Carvalho et al., 2006). ERAD-M
requires only a subset of these components. Finally, ERAD-C
uses a different ubiquitin ligase (Doa10p) (Swanson et al.,
2001). Following polyubiquitination, these pathways converge
at an ATPase complex, consisting of the ATPase Cdc48p and
two cofactors (Ufd1p and Npl4p) (Bays et al., 2001b; Braun
et al., 2002; Carvalho et al., 2006; Jarosch et al., 2002; Rabino-
vich et al., 2002; Ye et al., 2001).
Althoughmost, if not all, components have been identified, the
molecular mechanisms of the ERAD pathways remain unclear.
Some insight exists into the events that occur during ERAD-L
on the luminal and cytoplasmic sides of the ER membrane.
Misfolded, glycosylated ERAD-L substrates are initially recog-
nized in the ER lumen. Their prolonged residence time in the
ER results in the processing of their carbohydrate moiety to
generate a terminal a1,6 mannose residue (Bhamidipati et al.,
2005; Clerc et al., 2009; Kim et al., 2005; Quan et al., 2008;
Szathmary et al., 2005). This sugar, together with the unfolded
polypeptide segment surrounding the carbohydrate attachment
site, constitutes the degradation signal (Xie et al., 2009). The
signal is then recognized through a luminal domain of Hrd3p as
well as the lectin Yos9p (Denic et al., 2006; Gauss et al.,
2006a). Once the substrate appears on the cytoplasmic side of
the ER membrane, the RING finger domain of Hrd1p, together
with the ubiquitin-conjugating enzymes Ubc7p or Ubc1p, cata-
lyze polyubiquitination (Bays et al., 2001a; Bordallo et al.,
1998). The modified substrate is then recognized by the
Cdc48p/Ufd1p/Npl4p ATPase complex and moved into the
cytosol (Bays et al., 2001b; Braun et al., 2002; Jarosch et al.,
2002; Rabinovich et al., 2002; Ye et al., 2001). Finally, the
substrate is delivered to the proteasome and degraded.
The events of ERAD-L occurring inside the ER membrane are
unknown, particularly the mechanism by which substrates are
moved through the ER membrane. It has been proposed that
a retrotranslocation channel is required, and several channel
candidates have been considered (for review, see Hirsch et al.,
2009). Among the components of the Hrd1p complex, the
most attractive candidates are Der1p and its mammalian homo-
logs, the Derlins (Knop et al., 1996; Lilley and Ploegh, 2004; Ye
et al., 2004), as well as Hrd1p, simply because they possess
the largest number of transmembrane segments. In addition,
some studies suggest a role for the Sec61 channel, which isCell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc. 579
normally involved in the translocation of proteins from the cytosol
into the ER (Pilon et al., 1997; Scha¨fer and Wolf, 2009; Wiertz
et al., 1996; Willer et al., 2008; Zhou and Schekman, 1999).
However, there is no direct evidence in support of any of these
candidates, and it is not even clear whether a channel exists.
In fact, it has been suggested that translocation is instead linked
to the formation of lipid droplets (Ploegh, 2007). How the driving
force for retrotranslocation is provided is also unclear.Whereas it
is conceivable that the Cdc48p ATPase pulls on a polyubiquiti-
nated substrate once it appears on the cytosolic side of the
membrane, it is mysterious how energy would be provided for
moving the polypeptide through themembrane tomake it acces-
sible to the ubiquitination machinery. Finally, andmore generally,
the specific functions of the individual components of the Hrd1p-
complex are unknown, and it is unclear whether they act in
a temporal order during retrotranslocation of ERAD-L
substrates.
Here, we show that Hrd1p is the central membrane compo-
nent in the ERAD-L process and propose a model for polypep-
tide movement through the ER membrane.
RESULTS
Bypassing ERAD Components by Hrd1p Overexpression
In wild-type S. cerevisiae cells, all four components of the Hrd1p
complex (Hrd1p, Hrd3p, Usa1p, and Der1p) are essential for the
degradation of ERAD-L substrates (Knop et al., 1996; Taxis et al.,
2003; Gauss et al., 2006a ; Carvalho et al., 2006). However, we
reasoned that the overexpression of one component may
make other components dispensable, a result that would indi-
cate a functional hierarchy among these factors. These experi-
ments were also motivated by the previous observation that
overexpression of Hrd1p compensates for the absence of
Hrd3p (Gardner et al., 2000; Plemper et al., 1999), although
this result was interpreted as simply restoring the levels of
Hrd1p, which becomes unstable in a HRD3 deletion mutant.
We tested the effect of overexpression of Hrd1p on the degra-
dation of a well-characterized ERAD-L substrate, a misfolded
version of carboxypeptidase Y (CPY*) that is tagged with a C-
terminal hemagglutinin (HA) epitope (Finger et al., 1993; Ng
et al., 2000). In wild-type cells, CPY*-HA is degraded with
a half-life of 30 min (Figure 1A, lanes 1–4 and graph). When
the endogenous promoter for Hrd1p was replaced by the strong,
galactose-inducible GAL1 promoter and the cells were grown in
the presence of galactose, CPY*-HA degradation was acceler-
ated (Figure 1A, lanes 5–8). In the presence of glucose, when
the Gal promoter was repressed, CPY*-HA was stable, as ex-
pected from the depletion of Hrd1p (Figure S1A available online).
Although overexpressed Hrd1p is unstable, the steady-state
levels are increased by a factor of 10 (Figure S1B). CPY*-HA
degradation by overexpressed Hrd1p was much slower when
the ubiquitin-conjugating enzyme Ubc7p was absent (Figure 1A,
lanes 9–12) and was completely abrogated when an essential
cysteine in the RING finger domain of Hrd1p was mutated (Fig-
ure S1C). In addition, degradation was attenuated in a cdc48
mutant (Figure S1C). Thus, the requirements for ubiquitin-ligase
activity by Hrd1p and for the function of the Cdc48 ATPase are
maintained when Hrd1p is overexpressed.580 Cell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc.Next, we tested CPY*-HA degradation in cells that overex-
pressed Hrd1p but lacked other components of the Hrd1p
complex. As reported (Plemper et al., 1999), degradation was
not affected when Hrd3p was absent (Figure 1A, lanes 13–16).
Of interest, the process was also not affected by the absence
of Usa1p or Der1p (Figure 1A, lanes 17–20 and 21–24). More-
over, even in cells that simultaneously lacked Hrd3p, Usa1p,
and Der1p, the degradation of CPY*-HA was unimpeded (Fig-
ure 1A, lanes 25–28). Degradation in the triple-deletion mutant
required Hrd1p expression (Figure S1A) and ubiquitin ligase
activity (Figure S1D). These experiments indicate that Hrd1p
overexpression bypasses the need for the other components
of the Hrd1p complex. Similar results were obtained with KHN-
HA (a soluble protein) and KWW-HA (a membrane-bound
protein), both containing a misfolded luminal domain (Figure S2)
(Vashist and Ng, 2004).
The bypass effect observedwith Hrd1pwas not seenwhen the
other components of the Hrd1p complex were overexpressed.
Der1p under the Gal promoter did not accelerate CPY*-HA
degradation and did not alleviate the requirement for the other
Hrd1p complex components (Figure 1B). Usa1p or Hrd3p over-
expression blocked degradation of CPY*-HA (Figures 1C and
1D), indicating that excess of these components interferes with
the normal function of the Hrd1p complex. Taken together, our
data suggest that Hrd1p is the key component of the Hrd1p
complex and that the other subunits may have ancillary roles.
ERAD-L Substrate Degradation Requires Hrd1p
Oligomers
We hypothesized that Hrd1p overexpression bypasses the need
of the other Hrd1p complex components because Hrd1p must
oligomerize to be active in ERAD-L; in wild-type cells, the oligo-
merization would be regulated by other components of the
Hrd1p complex, whereas Hrd1p overexpression would force
its spontaneous oligomerization. Both our own previous experi-
ments and more recent results indicate that endogenous Hrd1p
forms high-molecular weight complexes whose size depends on
the presence of Usa1p, but not Hrd3p or Der1p (Carvalho et al.,
2006; Horn et al., 2009). To investigate directly the oligomeriza-
tion of Hrd1p, we expressed Myc- and HA-tagged versions of
Hrd1p in the same cell, both under the endogenous promoter.
Detergent-solubilized membrane extracts were then treated
with bifunctional crosslinking reagents and subjected to immu-
noprecipitation with HA antibodies. With extracts from wild-
type cells that were not treated with crosslinker, HA antibodies
precipitated Hrd1p-Myc (Figure 2A, top panel, lane 4), as previ-
ously described (Horn et al., 2009). Upon treatment with cross-
linkers, several high-molecular weight bands were observed
(Figure 2A, top panel, lanes 5 and 6). The highest molecular
weight band appeared with multiple crosslinkers and contains
not only Hrd1p, but also Usa1p (Figure 2A, bottom panel, lanes
5 and 6). With extracts lacking Usa1p, HA antibodies precipi-
tated only negligible amounts of Hrd1p-Myc or the crosslinked
bands (Figure 2A, bottom panel, lanes 1–3). Thus, Usa1p facili-
tates Hrd1p oligomerization.
Next, we identified the regions in Usa1p that are responsible
for Hrd1p interaction and oligomerization. Usa1p contains two
transmembrane segments flanked by long cytoplasmic domains
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Figure 1. Bypassing ERAD Components by Hrd1p Overexpression
(A) The degradation of the misfolded luminal ER protein CPY*-HA was followed after inhibition of protein synthesis by cycloheximide in wild-type (wt) cells or in
cells overexpressing Hrd1p under theGAL promoter in the presence of galactose.Where indicated, genes for ERAD components were deleted. The graph shows
quantification of the data.
(B) As in (A) but with overexpression of Der1p. The overexpression was confirmed by immunoblotting with specific antibodies (data not shown).
(C) As in (B) but with overexpression of Usa1p.
(D) As in (B) but with overexpression of Hrd3p.
See also Figure S1 and Figure S2.
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Figure 2. Usa1p-Mediated Oligomerization of Hrd1p Is Required for ERAD-L
(A) Hrd1p-HA and Hrd1p-Myc were coexpressed under the endogenous promoter in either wild-type (wt) or usaD cells. Detergent-solubilized membranes were
treated with the bifunctional crosslinkers DSS or EGS, as indicated. Following quenching of the crosslinking reaction, immunoprecipitation with HA antibodies
was performed. Bound proteins were analyzed by SDS-PAGE followed by immunoblotting withMyc or Usa1p antibodies. The arrowhead indicates the position of
a crosslinked species containing both Hrd1p and Usa1p.
(B) Hrd1p-HA and Hrd1p-Myc were coexpressed in cells containing either wild-type Usa1p or Usa1p mutants with the indicated deletions. Detergent-solubilized
membranes were subjected to immunoprecipitation (IP) with HA antibodies, and bound proteins were analyzed by SDS-PAGE and immunoblotting with HA, Myc,
or Usa1p antibodies. H and U indicate the segments in Usa1p that are responsible for interaction with Hrd1p and Usa1p, respectively.
(C) Usa1p-HA was coexpressed with FLAG-Usa1p or with the indicated FLAG-tagged deletion mutants of Usa1p. Detergent-solubilized membranes were sub-
jected to IP with HA antibodies, and bound proteins were analyzed by SDS-PAGE and immunoblotting with HA or FLAG antibodies. Lanes 5 and 8 and the cor-
responding lanes 13 and 16 show the results with two independent clones of the same construct.
(D) Hrd1p-HA and Hrd1p-Myc or Hrd1(C399S)-HA and Hrd1(C399S)-Myc were coexpressed in cells containing or lacking Usa1p. Detergent-solubilized
membranes were subjected to IP with HA antibodies, and bound proteins were analyzed by SDS-PAGE and immunoblotting with HA or Myc antibodies. For cells
lacking Usa1p, two independent clones coexpressing Hrd1p-HA and Hrd1p-Myc (lanes 5 and 6 and the corresponding lanes 13 and 14) or Hrd1(C399S)-HA and
Hrd1(C399S)-Myc (lanes 7 and 8 and the corresponding lanes 15 and 16) are shown.
(E) Kinetics of CPY*-HA degradation in cells expressing either wild-type Usa1p or the indicated deletion mutants. The levels of CPY*-HA were determined by
immunoblotting at different time points after cycloheximide addition (Figure S3). Shown are the means and standard deviations of three independent experi-
ments.
See also Figure S3.
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(Figure 2B). Preliminary experiments showed that the cyto-
plasmic region preceding the first transmembrane segment
was required for both Hrd1p oligomerization and Usa1p interac-
tion (data not shown). For amore precise analysis, we introduced
deletions into Usa1p (Figure 2B).We found a segment (437–490),
called segment H, whose deletion abolished both the binding of
Usa1p to Hrd1p and the oligomerization of Hrd1p (Figure 2B,
lane 12). Segment H likely interacts with the C-terminal 34 resi-
dues of Hrd1p (Horn et al., 2009). Another deletion (residues
319–418) left the interaction between Usa1p and Hrd1p intact
but significantly reduced Hrd1p oligomerization (Figure 2B,
lane 10). The region from 371 to 418, called segment U, appears
to be important for Hrd1p oligomerization because a deletion
mutant lacking residues 319–371 behaves like wild-type Usa1p
(Figure 2B, lane 9). A recent report suggested that the segment
from 259 to 312 encompassing the Ubl domain is responsible
for inducing oligomers of Hrd1p (Horn et al., 2009). However,
we did not observe any defects of Hrd1p oligomerization upon
complete deletion of the Ubl domain (259–318) (Figure S3A).
A simplemodel for Usa1p-dependent Hrd1p oligomerization is
that Usa1p itself forms oligomers through segment U and binds
Hrd1p through segment H (see scheme in Figure 7A). To test this
idea, we expressed HA-tagged full-length Usa1p together with
FLAG-tagged versions of Usa1p mutants, all under the endoge-
nous promoter. HA antibodies precipitated all Usa1p-FLAG
constructs, with the exception of the one lacking segment U
(Figure 2C). Similar results were obtained with hrd1D cells
(data not shown). These results support a model in which
Usa1p oligomers facilitate Hrd1p oligomerization. Based on
our overexpression experiments, it appears that Hrd1p has an
intrinsic propensity to form oligomers, which are stabilized by
Usa1p. Indeed, crosslinking experiments show that overex-
pressed Hrd1p can form high molecular weight species even in
the absence of Usa1p (Figure S3B). This is further supported
by experiments in which ERAD was inactivated by a mutation
of an essential cysteine in the RING finger of Hrd1p (C399S).
As expected (Horn et al., 2009), in the presence of Usa1p, this
mutant protein formed oligomers (Figure 2D, lane 11). Of interest,
however, Hrd1p (C399S) oligomerized even in the absence of
Usa1p (Figure 2D, lanes 15 and 16 versus lanes 13 and 14).
These data support the idea that Hrd1p has an intrinsic
propensity to oligomerize and also suggest that substrate flux
through the Hrd1p complex counteracts Usa1p-dependent
oligomerization.
Finally,we testedwhetherHrd1poligomerization is required for
ERAD-L. The Usa1p mutant lacking segment H was completely
inactive in the degradation of CPY* (Figure 2E and Figure S3C).
The deletion of segment U also significantly impaired ERAD but
did not completely block it, consistent with the residual Hrd1p
oligomerization activity (see Figure 2B). Thus, in contrast to
previous suggestions (Horn et al., 2009), our results indicate
that Hrd1p oligomerization is required for ERAD-L.
Crosslinking of an ERAD-L Substrate to the Hrd1p
Complex
Next, we tested whether an ERAD-L substrate undergoing retro-
translocation would interact with components of the Hrd1p
complex, particularly with the crucial membrane componentHrd1p. To test substrate interactions, we employed a site-
specific in vivo photocrosslinking method (Figure 3A) (Chen
et al., 2007; Chin et al., 2003). An ERAD-L substrate with an
amber stop codon at a selected site was expressed together
with a suppressor tRNA and a modified tRNA synthetase. The
synthetase charges the tRNA with a phenylalanine derivative
that carries a photoreactive benzophenone (Bpa), and the photo-
reactive amino acid analog is then incorporated at the position
specified by the stop codon. Irradiation of the cells leads to
crosslinks between the ERAD-L substrate and any protein that
is in close proximity to the photoreactive probe.
To reduce the number of crosslinking positions to be tested,
we used a shortened version of CPY* that contains the last 180
amino acids. This segment includes the glycosylation site that
is part of the degradation signal. In addition, we fused dihydrofo-
late reductase (DHFR) to the C terminus whose folding in the ER
lumen slows the degradation of the substrate (Bhamidipati et al.,
2005). Finally, three HA tags were added at the C terminus.
Degradation of this substrate (sCPY*-DHFR-HA) requires the
normal ERAD-L components, i.e., Yos9p, Hrd1p, Hrd3p,
Usa1p, and Der1p (Figure S4A). Next, we introduced single
amber stop codons at various positions of sCPY*-DHFR-HA
(Figure 3A; positions downstream and upstream of the glycosyl-
ation site are given positive and negative numbers, respectively).
Yeast cells harboring a plasmid coding for tRNA and tRNA
synthetase, as well as a plasmid coding for one of the sCPY*-
DHFR-HA amber mutants, were grown in the presence of Bpa
and then irradiated with UV light. Cell extracts were subjected
to immunoprecipitation with HA antibodies, followed by SDS-
PAGE and immunoblotting with HA antibodies (Figure 3B). In
the absence of the plasmid coding for tRNA and tRNA synthe-
tase, no HA-reactive protein was detected (data not shown),
demonstrating that suppression of the amber codon is required
to generate sCPY*-DHFR-HA. Upon UV irradiation, crosslinked
products were observed for most sCPY*-DHFR-HA mutants
(Figure 3B); no crosslinks were seen in the absence of an amber
codon (Figure S4B). The crosslinking pattern varied with the
position of the photoreactive probe (Figure 3B). These results
show that our approach can detect site-specific interactions of
sCPY*-DHFR-HA. However, the most prominent crosslinked
products could be extracted with alkali (data not shown), indi-
cating that they do not contain any of the integral membrane
proteins of the Hrd1p complex. In fact, one may expect that, at
any given time, only a small percentage of the luminal substrate
is moving through the membrane (Gauss et al., 2006b).
To test whether Hrd1p is among the less-prominent crosslink-
ing partners, the experiments were repeated in a strain that
expresses under the endogenous promoter Hrd1p with 13 Myc
tags at its C terminus (Hrd1-Myc), a modification that maintains
functionality of Hrd1p (Figure S4C). After irradiation, the samples
were subjected to immunoprecipitation with HA antibodies, fol-
lowed by immunoblotting with Myc antibodies (Figure 4A).
Crosslinks to Hrd1p were observed with positions +30, +40,
and +42, but not other positions. Amore refined screen indicated
that all positions between +30 and +42 crosslinked to Hrd1p,
with the strongest interaction seen at positions +35 to +41 (Fig-
ure 4B). Although the crosslinking efficiency was low (Table S1),
these data attest to the specificity of substrate interaction withCell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc. 583
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Figure 3. Site-Specific In Vivo Crosslinking
of an ERAD-L Substrate
(A) A shortened version of CPY* containing the last
180 amino acids, including the glycosylation site,
was fused to dihydrofolate reductase (DHFR) and
three HA tags (sCPY*-DHFR-HA). Single amber
stop codons (TAG) were introduced at different
sites of the coding sequence. The stop codon
was suppressed in vivo by expression of a
suppressor tRNA that is charged with the photo-
reactive amino acid analog benzoyl phenylalanine
(Bpa) by a modified amino acyl tRNA synthetase.
UV irradiation leads to crosslinks with proteins in
close proximity of the photoreactive probe. The
position of the probe is defined relative to the
glycosylation site (position 0; arrowhead; corre-
sponds to position 124 in sCPY*-DHFR-HA), with
amino acid residues upstream and downstream
given negative and positive numbers, respectively.
(B) Photoreactive probes were placed at the
indicated positions, and the cells were irradiated
with UV light, as indicated. Detergent-solubilized
membranes were subjected to immunoprecipita-
tion with HA antibodies, and bound proteins
were analyzed by SDS-PAGE and immunoblotting
with HA antibodies.
See also Figure S4.Hrd1p. Most positions gave two crosslinked bands in SDS gels,
which might represent crosslinks to different sites in Hrd1p, as
differences in mobility have been observed in other crosslinking
experiments (Plath et al., 1998). Similar results were obtained
when Hrd1p-Myc was first immunoprecipitated with Myc anti-
bodies, and the crosslinked products were analyzed by immuno-
blotting for sCPY*-DHFR-HA with HA antibodies (data not
shown). Taken together, these data show that Hrd1p interacts
directly with a specific region of the substrate that starts 30
amino acids downstream of the glycosylation site in the degra-
dation signal and extends for 12 amino acids almost to the
DHFR domain (see scheme in Figure 7B).
Next, we tested substrate interaction with the other compo-
nents of the Hrd1p complex in similar photocrosslinking experi-
ments. We first analyzed the crosslinking of sCPY*-DHFR-HA
with a functional version of the luminal domain of Hrd3p (amino
acids 1–767) containing 13 Myc tags at the C terminus (Hrd3[1–
767]-Myc) (Figure S4C). The most prominent crosslinks were
observed with probes at positions close to the degradation
signal (position +7), although other positions also showed interac-
tions (Figure 4C). These results are consistent with the proposal584 Cell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc.M
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rethat the luminal domain of Hrd3p interacts
with misfolded segments of ERAD-L
substrates (Denic et al., 2006; Gauss
et al., 2006a). Similar experiments were
performed with Der1p containing 13 Myc
tags at its C terminus (Der1-Myc), which
partially supports degradation of CPY*
(Figure S4D). Substrate interaction was
seen mostly for position +23 (Figure 4D).
Finally, a functional fusion of Usa1p to 13yc tags (Usa1-Myc) did not show any significant crosslinks,
xcept for a weak interaction with position +54 in the DHFR
omain (Figure 4E and Figure S4C). Together, these data suggest
at the crosslinks correspond to an early intermediate during ret-
translocation, where the substrate interacts with the Hrd1p
omplex on the luminal side of the ER membrane. The degrada-
on signal of the substrate is in contact with Hrd3p, a short
egmentdownstreamcontactsDer1p, and12 residues immedi-
tely following interact with Hrd1p (Figure 7B). The C-terminal
HFR moiety is also in the ER lumen (Bhamidipati et al., 2005).
he slow degradation of the substrate that is caused by the
HFR domain appears to allow the accumulation of this early
anslocation intermediate. Indeed, when the DHFR domain was
eleted, the resulting substrate (sCPY*-HA) was degraded much
ster than sCPY*-DHFR-HA, and photoreactive probes incorpo-
tedat equivalent positions did not give crosslinks toHrd1p (data
ot shown). Taken together, these results suggest that the
ubstrate inserts as a loop into the ERmembrane from the luminal
ide, contacting primarily Hrd1p. The length of the interacting
ubstrate segment indicates that no part of the polypeptide has
ached the cytosolic side of the ER membrane (Figure 7B).
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Figure 4. Site-Specific In Vivo Crosslinking of an
ERAD-L Substrate to Hrd1p Complex Components
(A) Photoreactive probes were placed at the indicated
positions of the substrate sCPY*-DHFR-HA. The
constructs were expressed in cells that harbor under the
endogenous promoter Hrd1p fused to 13 Myc tags
(Hrd1-Myc). After immunoprecipitation with HA anti-
bodies, the bound material was analyzed by SDS-PAGE
and immunoblotting with Myc antibodies.
(B) As in (A) but with a narrower range of positions of the
photoreactive probes.
(C) As in (A) but in cells that express under the endogenous
promoter the luminal domain of Hrd3p (amino acids 1–767)
fused to 13 Myc tags (Hrd3(1–767)-Myc).
(D) As in (A) but in cells that express under the endogenous
promoter Der1p fused to 13 Myc tags (Der1-Myc).
(E) As in (A) but in cells that express under the endogenous
promoter Usa1p fused to 13 Myc tags (Usa1-Myc).
(F) As in (A) but in cells expressing Myc-tagged Hrd1p or
mini-Hrd1p. As indicated in the diagram, mini-Hrd1p was
generated by deletion of the last four transmembrane
segments (TMs) of Hrd1p. RING refers to the RING finger
domain essential for ubiquitin ligase activity. The intensity
of the crosslinks to mini-Hrd1p was normalized to that of
wild-type Hrd1p. The numbers are the average of three
experiments.
See also Figure S5, Figure S6, and Table S1.To provide further evidence that the substrate interacts with
Hrd1p inside the membrane, we generated a mutant that lacks
four of the six transmembrane segments. The resulting construct
(mini-Hrd1p) contains the first two transmembrane segments
directly fused to the C-terminal cytoplasmic domain (Figure 4F).Cell 143, 579–Mini-Hrd1p is expressed at only slightly lower
levels than wild-type Hrd1p (Figure S5A), but it
is totally inactive in degrading CPY* (Figure S5B)
and two ERAD-M substrates (Sec61-2p and
Hmg2p-Myc; data not shown). However, it in-
teracts with the same ERAD components as
wild-type Hrd1p (Figure S5C) and forms oligo-
mers, although these appear to be less depen-
dent on the presence of Usa1p (Figure S3A). In
addition, it is unstable in the absence of Hrd3p
(Figure S5A), indicating that Hrd3p stabilizes
Hrd1p by interacting with the luminal domain
between transmembrane segments 1 and 2.
Mini-Hrd1p no longer gave photocrosslinks to
sCPY*-DHFR-HA (Figure 4F). Because trans-
membrane segments 3–6 are not required for
binding to ERAD components, they appear to
be involved in substrate interaction. Thus, in
the early translocation intermediate analyzed,
the substrate appears to form a loop that
contacts Hrd1p in the ER membrane, although
it remains unclear how deeply the loop inserts.
Because of the proposed role of the Sec61
channel in ERAD, we also tested whether
sCPY*-DHFR-HAwould crosslink to a functional
Sec61p fusion containing 13 Myc tags at its Cterminus (Sec61p-Myc). Very weak crosslinks were seen at posi-
tions +30, +37, +38, +40, and +54 (Figure S6A). The crosslinking
yields were at least two orders ofmagnitude lower than seenwith
components of the Hrd1p complex (Table S1). In addition, they
were not dependent on the presence of other ERAD components591, November 12, 2010 ª2010 Elsevier Inc. 585
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Figure 5. Effect of Luminal ERAD Events on Substrate-Hrd1p Crosslinking
(A) sCPY*-DHFR-HA or a mutant lacking the glycosylation site with photoreactive probes at the indicated positions were expressed in cells together with Hrd1-
Myc. Following UV irradiation, detergent-solubilized membranes were subjected to immunoprecipitation with HA antibodies, and bound proteins were analyzed
by SDS-PAGE and immunoblottingwithMyc antibodies. The intensity of the crosslinked band for the glycosylationmutant is given as a percentage of the intensity
obtained with sCPY*-DHFR-HA. The numbers are the average of two to four experiments.
(B) As in (A) but with sCPY*-DHFR-HA expressed in wild-type (wt) cells or cells lacking the indicated ERAD components. The numbers give percentage of cross-
linking intensity relative to wild-type and are the average of two to four experiments.
(C) As in (A) but with sCPY*-DHFR-HA expressed in cells harboring either wild-type Hrd3p or the indicated Hrd3p deletion mutants. The numbers are the average
of two experiments.
(D) As in (A) but with sCPY*-DHFR-HA expressed in yos9Dusa1D cells harboring the indicated Usa1p deletion mutants.
See also Figure S7.(Figure S6B), in contrast to those observed with Hrd1p (see
below). These results argue against a role of Sec61p in the retro-
translocation of the ERAD-L substrate.
Components Required for Substrate Interaction
with Hrd1p
Because our data suggest that Hrd1p is the key membrane
component in the ERAD-L pathway, we analyzed the interac-
tions between substrate and Hrd1p in greater detail. When
N-glycosylation at the critical site was prevented by a mutation
in sCPY*-DHFR-HA, crosslinking to Hrd1p was reduced (shown
for positions +30, +38, +40, and +42 in Figure 5A). Deletion of
YOS9 had a similar effect (Figure 5B), indicating that carbohy-
drate recognition by Yos9p affects substrate transfer to Hrd1p.
The Hrd1p crosslinks completely disappeared in an HRD3 dele-
tionmutant (data not shown). In principle, thismight be explained
by a reduction of the steady-state levels of Hrd1p in this strain586 Cell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc.(Gardner et al., 2000; Plemper et al., 1999). However, the
Hrd1p crosslinks were also absent in cells expressing a fragment
(residues 357–833) of the luminal domain of Hrd3p (Figure 5C)
even though this fragment partially restored the levels of Hrd1p
(data not shown and Gardner et al., 2000). Thus, substrate inter-
action with Hrd1p appears to critically depend on Hrd3p func-
tion. The recognition of the carbohydrate moiety by Yos9p,
although essential for the overall ERAD process, is less
important.
Substrate crosslinking to Hrd1p was only moderately reduced
in the absence of Usa1p (Figure 5B). This could be due to the role
of Usa1p in recruiting Der1p (Carvalho et al., 2006). Consistent
with this assumption, deletion of DER1 had reproducibly
a stronger effect on substrate-Hrd1p crosslinking than deletion
of USA1 (Figure 5B). When cells lacked Yos9p and Usa1p, or
Yos9p and Der1p, the crosslinks to Hrd1p completely disap-
peared (Figure 5B). These data suggest that there are two
AC
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 14  23  43  7  10  53parallel pathways for substrate delivery to Hrd1p, one involving
Yos9p and the other Der1p and Usa1p (Gauss et al., 2006b).
Consistent with this model, when cells lacked Usa1p and
Der1p, the crosslinks were reduced to approximately the same
level as seen in the absence of Usa1p alone (Figure S7A). Both
substrate delivery pathways to Hrd1p appear to require Hrd3p.
Our data also confirm that the Hrd1p-substrate crosslinks repre-
sent an early stage of translocation because, in usa1Dder1D
cells, substrate still interacts with the Hrd1p complex but is not
translocated across the membrane. To determine the domain
of Usa1p that is required for substrate-Hrd1p interaction, we ex-
pressed Usa1p mutants lacking either the H or U segment in
usa1Dyos9D cells. Hrd1p crosslinks were restored as long as
Usa1p contained the H segment (Figure 5D). These data are
consistent with the idea that Usa1p-Hrd1p interaction is required
to allow substrate delivery from Der1p to Hrd1p.
Although the Hrd1p-substrate crosslinks correspond to an
early retrotranslocation intermediate, they were dependent on
the ubiquitin ligase activity of Hrd1p; mutation of a critical Cys
residue in the RING domain of Hrd1p led to a substantial reduc-
tion of the Hrd1p crosslinks (Figure 6A). The same results were
obtained when the Cys mutation in Hrd1p was combined with
a deletion of USA1 (Figure 6B). The absence of Ubc7p also
reduced the Hrd1p crosslinking yields (Figure S7B); residual
crosslinking may be explained by the fact that Ubc1p can also
serve as a ubiquitin-conjugating enzyme in ERAD-L (Bays
et al., 2001a). Finally, Hrd1p crosslinks were also reduced in cells
expressing a cdc48 or npl4 temperature-sensitive mutant
(cdc48-3 or npl4-1; Figure 6C). Taken together, these data indi-
cate that the ubiquitination activity of Hrd1p and the function of
the Cdc48 ATPase, i.e., events that occur on the cytosolic side
of the ER membrane, are required for Hrd1p-substrate interac-
tion on the luminal side of the membrane.IP: sCPY*-DHFR-HA
Blot: Hrd1-MYC
 34  17  13
 10
Figure 6. Mutations of ERAD Components on the Cytosolic Side
Affect Substrate-Hrd1p Crosslinking
(A) sCPY*-DHFR-HA with photoreactive probes at the indicated positions was
expressed in cells together with Myc-tagged Hrd1p or a mutant defective in its
ubiquitin ligase activity (C399S). Following UV irradiation, detergent-solubi-
lized membranes were subjected to immunoprecipitation with HA antibodies,
and bound proteins were analyzed by SDS-PAGE and immunoblotting with
Myc antibodies. The numbers give percentage of crosslinking intensity relative
to wild-type and are the average of four experiments.
(B) As in (A) with either wt or usa1D cells. The numbers are the average of two
experiments.
(C) As in (A) with either wt cells or cells bearing the indicated temperature-
sensitive alleles of components of the Cdc48 ATPase complex analyzed after
1 hr incubation at the restrictive temperature of 37C. The numbers are the
average of two experiments.
See also Figure S7.DISCUSSION
Our results provide important insight into the mechanism of
ERAD-L. We show that the ubiquitin ligase Hrd1p is the key
membrane component for moving a misfolded protein across
the ER membrane. This conclusion is based on the observation
that the overexpression of Hrd1p bypasses the need for its inter-
action partners Hrd3p, Usa1p, and Der1p, whereas all down-
stream cytosolic components are still required. To function in
ERAD-L, Hrd1p needs to form homo-oligomers, a process that
is normally dependent on Usa1p, but can be induced in the
absence of Usa1p by the overexpression of Hrd1p. Using
a site-specific photocrosslinking approach, we demonstrate
that endogenous Hrd1p interacts directly with a substrate under-
going ERAD. This interaction requires the presence of trans-
membrane segments of Hrd1p and is dependent on the delivery
of substrate through other ERAD components. Unexpectedly,
substrate interaction with Hrd1p on the luminal side of the ER
membrane is also dependent on the ubiquitination activity of
Hrd1p and on the cytosolic Cdc48p ATPase complex. As dis-
cussed below, these results suggest a model for the mechanism
by which a misfolded luminal protein is moved through the
membrane.Our results indicate that Hrd3p, Usa1p, and Der1p are all regu-
lators of Hrd1p function. Hrd3p and Der1p are involved in
substrate delivery to Hrd1p, whereas Usa1p serves both to
recruit Der1p to Hrd1p and to induce Hrd1p oligomerization (Fig-
ure 7A). Usa1p facilitates Hrd1p oligomerization by interactingCell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc. 587
NN
N
N
N
N
N
N
Hrd1p
Usa1p
Der1p
Hrd3p
Yos9p
Ring
Usa1p
Der1p Hrd1p
Ring
Hrd3p
Yos9p
substrate
U
H
U
H
substrate
Hrd1p
Hrd3p
Ring
A
B
ER Lumen
Cytosol
ER Lumen
Cytosol
D
er
1p
DHFR
Figure 7. Organization of the Hrd1 Complex
and Its Interaction with Substrate
(A) The scheme summarizes interactions between
Hrd1p complex components, identified in the
present study and elsewhere (for references, see
text). For each protein, the N terminus is indicated.
Although not demonstrated, the C-terminal
domain of Der1p (dotted) likely interacts with the
C-terminal segment of Usa1p. The arrow indicates
interaction between two Usa1p molecules, which
facilitates oligomerization of the complex.
(B) The scheme shows the ERAD-L substrate at an
early stage of retrotranslocation, as analyzed by
photocrosslinking.with Hrd1p through one domain (segment H) and interacting with
another Usa1p molecule through another domain (segment U).
Our data show that Usa1p does not significantly interact with
substrate, consistent with it being a scaffolding protein (Horn
et al., 2009). Taken together with results in the literature
Carvalho et al., 2006; Denic et al., 2006; Gardner et al., 2000;
Gauss et al., 2006a, 2006b;Horn et al., 2009),wehavenowa fairly
comprehensive picture of the domain structure of the Hrd1p
complex components and their interactions (Figure 7A), although
it is possible that some of these associations are not permanent
but, rather, inducedbysubstrateor regulated inotherways.Upon
overexpression of Hrd1p, none of the regulatory components is
required, indicating that Hrd1p can spontaneously oligomerize
and bind substrates on its own. Under these conditions,
substrate selection is less specific (Denic et al., 2006).
In wild-type cells, Hrd3p is a crucial component for substrate
delivery to Hrd1p. Our photocrosslinking experiments indicate
that the luminal domain of Hrd3p interacts with substrate and
that, in the absence of Hrd3p, there is no transfer of substrate
to Hrd1p. Hrd3p appears to collaborate with two alternative
components to recruit substrate, either with Yos9p or Der1p,
because only the deletion of both components abolishes all
Hrd1p-substrate crosslinking. Dual delivery of substrate to
Hrd1p was suggested before on the basis of coimmunoprecipi-
tation experiments (Gauss et al., 2006b). Yos9p recognizes
a terminal a1,6 mannose residue on a carbohydrate chain
attached to the substrate (Clerc et al., 2009; Quan et al., 2008).
We found that Der1p directly interacts with substrate, but its
precise role remains unclear. Because both Yos9p and Der1p
are essential in ERAD-L, they must have nonredundant functions
in addition to providing parallel pathways of substrate
recruitment.
The photocrosslinking experiments give us a snapshot of an
early translocation intermediate that follows substrate recogni-588 Cell 143, 579–591, November 12, 2010 ª2010 Elsevier Inc.th
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totion (Figure 7B). The data show that
Hrd1p interacts with an 12 amino acid
region of the sCPY*-DHFR-HA substrate.
The interacting segment starts about 30
amino acid residues downstream of the
glycosylation site in the degradation
signal and immediately precedes the
DHFR domain (Figure 7B). The polypep-
tide likely interacts with Hrd1p close toe luminal side of the membrane because the degradation
ignal is in contact with the luminal domain of Hrd3p, and the
HFR moiety is also in the ER lumen (Bhamidipati et al., 2005).
hus, following recognition of the degradation signal and while
till bound to Hrd3p, the adjacent C-terminal segment of the
olypeptide chain interacts with Hrd1p. Given that the last four
ansmembrane segments of Hrd1p are required for substrate
teraction, it appears that the polypeptide chain is inserted
to the membrane-embedded parts of Hrd1p, likely as a loop.
owever, considering the length of the crosslinking region in
e substrate, the polypeptide cannot be inserted deeply into
rd1p, certainly not completely across the membrane. The N-
rminal part of the substrate loop contacts Der1p (Figure 7B),
uggesting that Der1p may play a role in inserting the polypep-
de into Hrd1p.
Our data would be consistent with the assumption that the
ubstrate interacts with a Hrd1p monomer because the cross-
nking yields were only moderately reduced in the absence of
sa1p, the component required for efficient Hrd1p oligomeriza-
on. Because the crosslinking efficiency is rather low, it is also
ossible that the substrate crosslinks to a small population of
pontaneously generated Hrd1p oligomers. However, dissocia-
on of the Hrd1p oligomer upon substrate binding would be
onsistent with the observation that blocking substrate flux
rough Hrd1p, either by mutation of its critical cysteine or by
eletion of four of its transmembrane segments, makes Hrd1p
ligomerization less dependent on the presence of Usa1p. We
erefore propose that substrate and Usa1p have opposing
ffects on the oligomerization of Hrd1p.
Surprisingly, we found that the ubiquitin ligase activity of
rd1p is required for an early interaction of substrate with
rd1p. Because no part of the substrate has yet emerged on
e cytoplasmic side of the membrane to become accessible
the ubiquitination machinery, these results suggest that
Hrd1p modifies a target that is different from the substrate.
The simplest possibility is that Hrd1p ubiquitinates another
Hrd1p molecule, although this modification would not be ex-
pected to result in polyubiquitination because Hrd1p is stable
in wild-type cells. We do not have direct evidence for self-
ubiquitination of endogenous Hrd1p, but it is well established
that Hrd1p can modify itself upon overexpression or in the
absence of Hrd3p (Bays et al., 2001a; Carroll and Hampton,
2010). Furthermore, the retrotranslocation of two substrates
that are not ubiquitinated themselves still requires the ubiquiti-
nation activity of the ligase (Bernardi et al., 2010; Hassink
et al., 2006).
Our results also show that the activity of the Cdc48p ATPase
complex is involved at an early stage of retrotranslocation, likely
the same that is dependent on Hrd1p ligase activity, given that
the Cdc48p complex is generally recruited to ubiquitinated
targets (Ye, 2006). An attractive possibility is that the Cdc48p
ATPase remodels the Hrd1p complex following self-ubiquitina-
tion, either changing its conformation or its oligomeric state,
a model that would be consistent with known activities of
Cdc48p in other processes (Ramadan et al., 2007; Rape et al.,
2001; Ye, 2006).
Based on our results, we propose a simple model for how
a polypeptide is moved through the membrane. Because
Hrd1p is the crucial component of the Hrd1p complex and needs
to form oligomers, it may surround a polypeptide chain during its
movement through the membrane. The polypeptide loop that is
inserted into Hrd1p at the beginning of retrotranslocation might
simply be extended, with the transmembrane segments of the
Hrd1p oligomer offering transient binding sites for the substrate
inside the membrane. Because substrate and Usa1p have
opposing effects on the oligomerization of Hrd1p, Hrd1p oligo-
mers appear to be destabilized by substrate binding. The self-
ubiquitination of Hrd1p and subsequent Cdc48p ATPase activity
may be required for conformational changes of the Hrd1p-
substrate complex. One possibility is that Hrd1p undergoes
repeated cycles of Cdc48p- and ATP-dependent dissociation
and Usa1p-dependent association, which may be coupled to
cycles of substrate binding and release. Once the substrate
loop has emerged on the cytosolic side of the membrane, it
can be polyubiquitinated by Hrd1p and pulled out of the
membrane by the Cdc48p ATPase complex. According to this
model, Hrd1p alone would provide the conduit for a polypeptide
through the ER membrane. Our photocrosslinking data argue
against the proposed role for the Sec61 channel in retrotranslo-
cation, but the participation of this or other components can only
be formally excluded upon reconstitution of the process with
purified proteins.
The proposed model could also apply to the degradation of
proteins that have their misfolded domains inside of the ER
membrane (ERAD-M). Because Usa1p is not required for all
ERAD-M substrates (Carroll and Hampton, 2010; Carvalho
et al., 2006; Horn et al., 2009), onemight assume that the binding
of Hrd1p to different regions of the membrane-embedded
substrate would promote Hrd1p oligomerization. Although
many of the details of ERAD-L and -M remain to be elucidated,
it is now clear that future work has to concentrate on Hrd1p
and its regulation by the Cdc48p ATPase complex.EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
Tagging of proteins and individual gene deletions were performed by standard
PCR-based homologous recombination (Longtine et al., 1998). Strains with
multiple gene deletions and/or genomically encoded fusion proteins were
made by PCR-based homologous recombination (Longtine et al., 1998) or
by crossing haploid cells of opposite mating types, followed by sporulation
and tetrad dissection using standard protocols (Guthrie and Fink, 1991). The
strains used are isogenic either to BY4741 (Mata ura3D0 his3D1 leu2D0
met15D0) or to FY251 (Mata ura3-52 his3D200 leu2D1 trp1D63) and are listed
in Table S2. Plasmids used in this study are listed in Table S3 and described in
Extended Experimental Procedures.
ERAD-Substrate Degradation Experiments
Cycloheximide shutoff experiments were performed in exponentially growing
cells, as described (Gardner et al., 2000). For experiments in which one of
the ERAD components was expressed from the GAL1 promoter, cells were
grown for three to five doubling times in medium containing 3% raffinose for
derepression of the promoter. ERAD components were then overexpressed
in medium containing 3% galactose for 5 to 16 hr before performing cyclohex-
imide shutoff experiments.
Chemical Crosslinking and Immunoprecipitations
A membrane fraction derived from 40–80 OD600 units of cells was isolated as
previously described (Carvalho et al., 2006) and solubilized in 50 mM HEPES/
KOH (pH 7.9), 200 mM NaCl, and 2 mM MgCl2 containing 1% digitonin or 1%
Nonidet P-40. For chemical crosslinking experiments, the extracts were incu-
batedwith 0.2mMdisuccinimidyl suberate (DSS) or 0.2mMethylene glycol bis
[succinimidylsuccinate] (EGS) for 30 min at room temperature. The reaction
was quenched with 50 mM Tris/HCl (pH 7.4) for 10 min. Immunoprecipitation,
SDS-PAGE with 4%–20% gradient gels, and immunoblotting were performed
as described previously (Carvalho et al., 2006). In all immunoprecipitation
experiments, 5% of the lysate was used directly for SDS-PAGE and
immunoblotting.
Site-Specific In Vivo Photocrosslinking
Cells were cotransformed with two plasmids, one coding for a tRNA that
suppresses the amber stop codon and a modified tRNA-synthetase that
charges the tRNA with the photoreactive amino acid analog benzoyl phenylal-
anine (Bpa), and another one coding for sCPY*-DHFR-HA with an amber stop
codon at a selected position (Chen et al., 2007; Chin et al., 2003). The cells
were grown overnight at 30C in 150 ml of minimal medium. At OD600 of
0.3–0.5, 0.2 mM of Bpa was added (from a stock solution of 0.2 M Bpa in
1 M NaOH) for 3 to 5 hr at 25C. The cells were harvested, washed with cold
water, and resuspended in 1 ml of water. One-half of the cells was transferred
to a 12-well plate and exposed to long-range UV irradiation for 45 min using
a B-100AP lamp (UVP, CA); the other half of the cells was kept on ice and used
as control. Cells were lysed in LB buffer (50 mM Tris/HCl [pH 7.4], 200 mM
NaCl, 1mMEDTA, 2mMphenylmethylsulfonyl fluoride (PMSF), and a protease
inhibitor cocktail (Roche) using glass beads in a bead beater (Biospec). The
lysates were cleared by a 10 min centrifugation at 600 3 g, and a crude
membrane fraction was obtained from the supernatant by a 20 min centrifuga-
tion at 100,000 3 g. The membranes were solubilized at 65C in urea buffer
(50 mM Tris/HCl [pH 7.4], 1 mM EDTA, 1%SDS, 2M urea). Following dilution
with LB buffer containing 1% Nonidet P-40, the extracts were incubated
with HA antibodies (1:2000; rat monoclonal clone 3F10, Roche) and protein
G Sepharose (GE Healthcare). Bound proteins were eluted with SDS buffer
and analyzed by SDS-PAGE and immunoblotting.SUPPLEMENTAL INFORMATION
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